Impact of carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer (DRPC) on free testosterone levels.
C. W. Reuter
No relevant relationships to disclose
M. A. Morgan
No relevant relationships to disclose
M. Fenner
No relevant relationships to disclose
P. Ivanyi
No relevant relationships to disclose
V. Gruenwald
No relevant relationships to disclose
A. Ganser
No relevant relationships to disclose